U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment
ArchIntel
JUNE 2, 2021
While the demand seemingly outpaces the industry’s ability to produce treatments for the pandemic, the quest to develop the “silver bullet” against COVID-19 is expected to drive competition in the industry. This fierce competition is predicted to propel the U.S. Volkan Gunduz, Associate Director of CI, Sanofi Genzyme.
104 
Let's personalize your content